5-bromo-4-chloro-3-indolyl beta-galactoside and Kallmann Syndrome

5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with Kallmann Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Archambeaud, F; Baral, V; Bertherat, J; Bodereau, V; Bondurand, N; Chaoui, A; Dodé, C; Dupin-Deguine, D; Fouveaut, C; Francannet, C; Goossens, M; Hardelin, JP; Kurtz, FJ; Leroy, C; Marcos, S; Marlin, S; Pingault, V; Vérier-Mine, O; Watanabe, Y; Young, J	1

Other Studies

1 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and Kallmann Syndrome

Article	Year
Loss-of-function mutations in SOX10 cause Kallmann syndrome with deafness. American journal of human genetics, 2013, May-02, Volume: 92, Issue:5 Topics: Animals; Deafness; DNA Mutational Analysis; Female; France; Galactosides; Genetic Predisposition to Disease; HeLa Cells; Humans; Indoles; Kallmann Syndrome; Male; Mice; Mutation; Neuroglia; Olfactory Pathways; Plasmids; SOXE Transcription Factors	2013

Article

Year

Loss-of-function mutations in SOX10 cause Kallmann syndrome with deafness.

American journal of human genetics, 2013, May-02, Volume: 92, Issue:5

Topics: Animals; Deafness; DNA Mutational Analysis; Female; France; Galactosides; Genetic Predisposition to Disease; HeLa Cells; Humans; Indoles; Kallmann Syndrome; Male; Mice; Mutation; Neuroglia; Olfactory Pathways; Plasmids; SOXE Transcription Factors

2013